These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients. Fodstad H; Bendahhou S; Rougier JS; Laitinen-Forsblom PJ; Barhanin J; Abriel H; Schild L; Kontula K; Swan H Ann Med; 2006; 38(4):294-304. PubMed ID: 16754261 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of ventricular pacing in the treatment of an arrhythmic storm associated with a congenital long QT mutation. Aziz PF; Shah MJ Congenit Heart Dis; 2013; 8(6):E165-7. PubMed ID: 23075154 [TBL] [Abstract][Full Text] [Related]
5. Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland. Fodstad H; Swan H; Laitinen P; Piippo K; Paavonen K; Viitasalo M; Toivonen L; Kontula K Ann Med; 2004; 36 Suppl 1():53-63. PubMed ID: 15176425 [TBL] [Abstract][Full Text] [Related]
6. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk. ter Bekke RM; Haugaa KH; van den Wijngaard A; Bos JM; Ackerman MJ; Edvardsen T; Volders PG Eur Heart J; 2015 Jan; 36(3):179-86. PubMed ID: 25205533 [TBL] [Abstract][Full Text] [Related]
7. High prevalence of four long QT syndrome founder mutations in the Finnish population. Marjamaa A; Salomaa V; Newton-Cheh C; Porthan K; Reunanen A; Karanko H; Jula A; Lahermo P; Väänänen H; Toivonen L; Swan H; Viitasalo M; Nieminen MS; Peltonen L; Oikarinen L; Palotie A; Kontula K Ann Med; 2009; 41(3):234-40. PubMed ID: 19160088 [TBL] [Abstract][Full Text] [Related]
8. Atrioventricular block-induced Torsades de Pointes with clinical and molecular backgrounds similar to congenital long QT syndrome. Oka Y; Itoh H; Ding WG; Shimizu W; Makiyama T; Ohno S; Nishio Y; Sakaguchi T; Miyamoto A; Kawamura M; Matsuura H; Horie M Circ J; 2010 Nov; 74(12):2562-71. PubMed ID: 20975234 [TBL] [Abstract][Full Text] [Related]
9. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit. Jacobson I; Carlsson L; Duker G J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633 [TBL] [Abstract][Full Text] [Related]
10. A case series of drug-induced long QT syndrome and Torsade de Pointes. Tong KL; Lau YS; Teo WS Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578 [TBL] [Abstract][Full Text] [Related]
11. Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations. Zhang X; Chen S; Zhang L; Liu M; Redfearn S; Bryant RM; Oberti C; Vincent GM; Wang QK BMC Med Genet; 2008 Sep; 9():87. PubMed ID: 18808722 [TBL] [Abstract][Full Text] [Related]
13. Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome. Itoh H; Sakaguchi T; Ding WG; Watanabe E; Watanabe I; Nishio Y; Makiyama T; Ohno S; Akao M; Higashi Y; Zenda N; Kubota T; Mori C; Okajima K; Haruna T; Miyamoto A; Kawamura M; Ishida K; Nagaoka I; Oka Y; Nakazawa Y; Yao T; Jo H; Sugimoto Y; Ashihara T; Hayashi H; Ito M; Imoto K; Matsuura H; Horie M Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):511-23. PubMed ID: 19843919 [TBL] [Abstract][Full Text] [Related]
14. Functional assessment of compound mutations in the KCNQ1 and KCNH2 genes associated with long QT syndrome. Grunnet M; Behr ER; Calloe K; Hofman-Bang J; Till J; Christiansen M; McKenna WJ; Olesen SP; Schmitt N Heart Rhythm; 2005 Nov; 2(11):1238-49. PubMed ID: 16253915 [TBL] [Abstract][Full Text] [Related]
15. Fragmented QRS is associated with torsades de pointes in patients with acquired long QT syndrome. Haraoka K; Morita H; Saito Y; Toh N; Miyoshi T; Nishii N; Nagase S; Nakamura K; Kohno K; Kusano KF; Kawaguchi K; Ohe T; Ito H Heart Rhythm; 2010 Dec; 7(12):1808-14. PubMed ID: 20837161 [TBL] [Abstract][Full Text] [Related]
16. Long QT and Brugada syndrome gene mutations in New Zealand. Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336 [TBL] [Abstract][Full Text] [Related]
17. Molecular predictors of drug-induced prolongation of the QT interval. Dilaveris PE Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):105-18. PubMed ID: 15853698 [TBL] [Abstract][Full Text] [Related]
18. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome. Wegener FT; Ehrlich JR; Hohnloser SH Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559 [No Abstract] [Full Text] [Related]
19. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population. Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276 [TBL] [Abstract][Full Text] [Related]